Literature DB >> 15146556

BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families.

Michelle D Reeves1, Tali M Yawitch, Nerina C van der Merwe, Hester J van den Berg, Greta Dreyer, Elizabeth J van Rensburg.   

Abstract

Germ-line mutations within BRCA1 are responsible for different proportions of inherited susceptibility to breast/ovarian cancer, and the spectrum of mutations within this gene is often unique to certain populations. At this time, there have been no reports regarding the role of BRCA1 in South African breast and/or ovarian cancer families. We therefore screened 90 South African breast/ovarian cancer families for BRCA1 mutations by means of PCR-based mutation detection assays. Eighteen families (20%) were identified with BRCA1 disease-causing mutations. Four Ashkenazi Jewish families were identified with the 185delAG mutation, whereas 2 Afrikaner and 1 Ashkenazi Jewish family were found to harbor the 5382insC mutation. Five of the families (5.56%), all of whom are Afrikaners, were found to carry the novel E881X mutation. Genotype analyses show that these patients share a common ancestor. Genealogic studies have identified 3 possible founding couples for this mutation, all of whom arrived in the Cape from France in the late 1600s. Of the remaining mutations detected, 3 have not been reported previously and include the S451X, 1493delC (detected twice) and 4957insC mutations. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15146556     DOI: 10.1002/ijc.20186

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.

Authors:  H Wu; X Wu; Z Liang
Journal:  Gene Ther       Date:  2017-08-03       Impact factor: 5.250

2.  Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal.

Authors:  Rokhaya Ndiaye; Jean Pascal Demba Diop; Violaine Bourdon-Huguenin; Ahmadou Dem; Doudou Diouf; Mamadou Moustapha Dieng; Pape Saloum Diop; Serigne Modou Kane Gueye; Seydi Abdoul Ba; Yacouba Dia; Sidy Ka; Babacar Mbengue; Alassane Thiam; Maguette Sylla Niang; Papa Madieye Gueye; Oumar Faye; Philomene Lopez Sall; Aynina Cisse; Papa Amadou Diop; Hagay Sobol; Alioune Dieye
Journal:  NPJ Genom Med       Date:  2020-01-31       Impact factor: 8.617

3.  Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.

Authors:  Rencia van der Sluis
Journal:  Mol Genet Genomics       Date:  2018-06-14       Impact factor: 3.291

Review 4.  Mutations in context: implications of BRCA testing in diverse populations.

Authors:  Gabriela E S Felix; Yonglan Zheng; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

5.  The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.

Authors:  Chuan-Gui Song; Zhen Hu; Jiong Wu; Jian-Min Luo; Zhen-Zhou Shen; Wei Huang; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

6.  Breast cancer in young women in a limited-resource environment.

Authors:  Sarinah Basro; Justus P Apffelstaedt
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

7.  Low Prevalence of the Four Common Colombian Founder Mutations in BRCA1 and BRCA2 in Early-Onset and Familial Afro-Colombian Patients with Breast Cancer.

Authors:  Elizabeth Vargas; Diana Maria Torres Lopez; Robert de Deugd; Fabian Gil; Alejandra Nova; Lina Mora; Luis Fernando Viaña; José David Hernandez; Ricardo Bruges; Ute Hamann
Journal:  Oncologist       Date:  2018-12-12

8.  PALB2 sequence variants in young South African breast cancer patients.

Authors:  Michelle Sluiter; Samantha Mew; Elizabeth J van Rensburg
Journal:  Fam Cancer       Date:  2009-03-31       Impact factor: 2.375

9.  CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application.

Authors:  Nicole van der Merwe; Christianne S H Bouwens; Rika Pienaar; Lize van der Merwe; Yandiswa Y Yako; Dieter H Geiger; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2012-05-26       Impact factor: 3.584

10.  Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients.

Authors:  Jun Li; Sile Han; Cuiyun Zhang; Yanlin Luo; Li Wang; Ping Wang; Yi Wang; Qingxin Xia; Xiaoyan Wang; Bing Wei; Jie Ma; Hongle Li; Yongjun Guo
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.